|
|
||||||||
1 Departments of Physiology and Pharmacology, 2 Obstetrics and Gynaecology, and 3 Medicine, Lawson Health Research Institute, University of Western Ontario, London, Ontario, Canada N6A 4V2
| |
ABSTRACT |
|---|
|
|
|---|
Mechanical ventilation is a necessary intervention for patients with acute lung injury. However, mechanical ventilation can propagate acute lung injury and increase systemic inflammation. The exposure to >21% oxygen is often associated with mechanical ventilation yet has not been examined within the context of lung stretch. We hypothesized that mice exposed to >90% oxygen will be more susceptible to the deleterious effects of high stretch mechanical ventilation. C57B1/6 mice were randomized into 48-h exposure of 21 or >90% oxygen; mice were then killed, and isolated lungs were randomized into a nonstretch or an ex vivo, high-stretch mechanical ventilation group. Lungs were assessed for compliance and lavaged for surfactant analysis, and cytokine measurements or lungs were homogenized for surfactant-associated protein analysis. Mice exposed to >90% oxygen + stretch had significantly lower compliance, altered pulmonary surfactant, and increased inflammatory cytokines compared with all other groups. Our conclusion is that 48 h of >90% oxygen and high-stretch mechanical ventilation deleteriously affect lung function to a greater degree than stretch alone.
pulmonary surfactant; inflammatory cytokines
| |
INTRODUCTION |
|---|
|
|
|---|
MECHANICAL VENTILATION IS a necessary therapeutic intervention for patients with acute lung injury (ALI) and acute respiratory distress syndrome (ARDS); the goal of such intervention is to maintain adequate oxygenation (1, 9). However, mechanical ventilation can also propagate the injury to the lung by altering the pulmonary surfactant system and increasing the local production of cytokines (9, 28, 29). The importance of mechanical ventilation in the pathophysiology of ALI/ARDS was recently demonstrated in a National Institute of Health-funded clinical trial (6). This large, multicenter study of mechanical ventilation compared low tidal volumes to the traditional, higher tidal volume ventilation strategies in patients with ALI/ARDS. The data from this study demonstrated a significantly lower mortality in patients who were managed with the ventilation strategy that reduced the amount of lung stretch. Despite these results, ALI/ARDS remains associated with a high mortality rate.
One aspect of mechanical ventilation that has received a limited amount of attention is the exposure to greater than normal concentrations of oxygen often associated with mechanical ventilation. In fact, many of the clinical trials examining the effects of tidal volumes included variable and prolonged exposures to high oxygen (5, 6, 27). Various studies have been published on the effects of exposure to high oxygen concentrations; however, the focus has been on the development of long-term oxidative stress-induced lung injury (16). The effect of oxygen exposure in the context of lung stretch has not been previously investigated.
Alterations to the endogenous pulmonary surfactant system have been proposed as a mechanism by which both lung stretch and high oxygen exposure can damage lungs (14, 30, 31). Pulmonary surfactant is a mixture of lipids and surfactant-associated proteins that are responsible for stabilizing the lung by reducing surface tension at the air-liquid interface (22). The lipid fraction of surfactant consists mostly of phospholipids, of which dipalmitoylphosphatidylcholine (DPPC) is most abundant and essential for the surface tension-reducing properties (22). Within the lung, the surface activity of surfactant is accomplished by one of two alveolar subfractions, the active large aggregates (LA). The other subfraction, the small aggregates (SA), is the product of LA metabolism and is functionally inactive (17, 32). In a healthy lung, there is a continuous turnover of surfactant that maintains relative amounts of LA and SA with a consistent lipid and protein composition. In contrast, in severely injured lungs, there are significant changes to the surfactant system; the relative amounts of LA are decreased, SA are increased (12, 17), and the phospholipid and protein compositions are altered. Furthermore, lung injury results in an increased leakage of serum protein into the lung and an increased production of inflammatory cytokines (19). Together, these changes contribute to decreased lung stability, decreased oxygenation, and increased inflammation in the injured lung.
The purpose of this study was to examine the effect of high oxygen exposure on lung function within a model of lung stretch. We hypothesized that exposure to high oxygen enhances the damaging effects of lung stretch through alterations of the pulmonary surfactant system and increases in proinflammatory cytokines.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
A total of 106 C57B1/6 mice (Charles River Laboratory) weighing 18-32 g were used for these experiments. The mice were group housed and allowed access to standard rodent chow and water ad libium with an automatically controlled 12-h light-dark cycle. All mice were allowed a minimum 4-day acclimatization period before randomization into the experiments described below. All procedures performed on the mice were approved by the animal use subcommittee of the University of Western Ontario.
Four groups of animals were investigated: 1) 48-h exposure
to 21% oxygen (21% nonstretch); 2) 48-h exposure to >90%
oxygen (>90% nonstretch); 3) 48-h exposure to 21% oxygen
followed by 2 h of high stretch, ex vivo mechanical ventilation
(21% + stretch); and 4) 48-h exposure to >90% oxygen
followed by 2 h of high stretch, ex vivo mechanical ventilation
(>90% + stretch). Because of the low amounts of material obtained
from each animal, four separate subgroups of animals from these
experimental groups were used for 1) surfactant analysis of
bronchoalveolar lavage (BAL), 2) determination of surfactant
protein (SP)-A and D protein levels in homogenized lung tissue,
3) measurements of mRNA of surfactant-associated proteins,
and 4) analysis of TNF-
and IL-6 in the BAL.
Animal procedures. Initially, mice were randomized into one of two groups: normal air (21% oxygen) or high oxygen (>90% oxygen). Oxygen concentrations were controlled by a gas mixer (model 3500HL, Sechrist Medical Products Division, Anaheim, California) that was supplied by the hospital's medical air and oxygen lines. A sealed Plexiglas box (55 × 50 × 32.5 cm, Parker Plastic, Ontario, Canada) was filled with the appropriate gas mixture, and, after an initial body weight was recorded, mice were placed inside for a duration of 48 h. Oxygen levels inside the box were verified every 12 h with a MiniOx-I oxygen analyzer (MSA Medical Products, Pittsburgh, PA).
After the 48-h exposure, mice were again weighed and then killed with an intraperitoneal overdose injection (0.5 ml) of pentobarbital sodium (65 mg/ml) and exsanguinated via cutting of the descending dorsal aorta. After death, 2-0 surgical silk was used to secure a catheter in the trachea (18 gauge). The lung was then carefully extracted from the thoracic cavity and randomized into one of two groups: nonventilation (nonstretch) and ex vivo mechanical ventilation (stretch). Briefly, isolated lungs were placed inside a 37°C humidified chamber and mechanically ventilated with a volume cycle Voltek R5 rodent ventilator (Voltek Enterprises, Toronto, Canada), with an inspired oxygen fraction of 1.0 for 2 h with a tidal volume of 20 ml/kg and zero end-expiratory pressure at a rate of 40 cycles/min (31). Peak inspiratory pressures (PIP) were monitored every 30 min throughout the 2-h ventilation period. At the completion of ventilation (immediately after lung isolation for the nonstretch group), a static pressure-volume curve was determined to assess the compliance of the lung at a maximum pressure of 25 cmH20 (31).BAL and surfactant analysis.
After compliance measurements, a BAL was performed by using 1-ml wash
of 0.15 M NaCl saline three times. Each lavage comprised instilling and
withdrawing the saline via the tracheal catheter three times by using a
1-ml syringe. All lavages were combined, and total volumes were
recorded. BAL material was centrifuged at 150 g for 10 min
to remove any cellular debris. The supernatant was termed total
surfactant (TS) and stored at
20°C, with the exception of a 1-ml
aliquot that was further centrifuged at 40,000 g for 15 min
to separate the SA in the supernatant from the LA in the pellet. LA
were resuspended in 300 µl of saline, and both LA and SA were
similarly frozen and stored at
20°C.
Extraction of mRNA and analyses.
Whole lung RNA was extracted by using the Trizol reagent method,
following the instructions provided by the supplier (Life Technologies,
Grand Island, NY). Briefly, the lungs were isolated with RNase-free
instruments and placed in 1 ml of Trizol reagent; the lungs were then
homogenized with a polytron PT2100 (Kinematica, Luzern, Switzerland) at
20,000 rpm. After addition of chloroform, incubation at 30°C, and
centrifugation at 16,000 g, the upper aqueous layer was
extracted and precipitated with isopropyl alcohol. The pellet was
subjected to a series of wash and dry steps, and 3 µg of the pellet
were loaded on a 1% agarose gel to ensure the stability of the RNA.
The remainder of the pellet was stored at
70°C until further use.
-35S),
probed for SP-A, SP-B, SP-C, and SP-D, and the housekeeping genes L32
and GAPDH, which were used as internal loading controls. The RNA
protection assay gel was absorbed onto filter paper and exposed to
X-ray film (Eastman Kodak, Rochester, NY) for 72 h at
70°C.
The film was subsequently analyzed by densitometry by using GAPDH as an
internal loading control.
Quantification of SP-A and SP-D via Western blot.
Lungs were homogenized in 1 ml of saline with a polytron PT2100. The
homogenate was then diluted another 10× with saline and stored at
20°C until analysis. A Lowry protein assay (18) was performed on the diluted homogenate, and subsequently 100 µg of homogenate protein were loaded on a 12% polyacrylamide gel containing 0.01% sodium dodecyl sulphate. Proteins were separated via 2 h of
100-V electrophoresis (Bio-Rad Laboratories, Mississauga, Canada), after which the proteins were transferred to a nitrocellulose membrane
(Bio-Rad Laboratories). Nitrocellulose membranes for SP-A analysis were
blocked at 4°C overnight in 3% Blotto in PBS (pH 7.4). The
nitrocellulose was then incubated in rabbit anti-rat SP-A IgG primary
antibody in a 1:700 dilution with 1× PBS. Nitrocellulose membranes
were then washed 3 × 5 min in 1× PBS with 0.01% Tween 20 followed by incubation with goat anti-rabbit horseradish
peroxidase-linked secondary antibody diluted 1:1,000 in 1× PBS.
Nitrocellulose membranes for SP-D analysis were blocked at 4°C
overnight in 5% Blotto in Tris-buffered saline (TBS; pH 7.6). The
nitrocellulose was then incubated in rabbit anti-mouse recombinant SP-D
IgG primary antibody in a 1:5,000 dilution with 5% Blotto in 1× TBS.
The nitrocellulose was washed for 5 min in 1× TBS, 5 min in TBS with
0.01% Tween 20, 3 × 5 min in 1× TBS, followed by a 5-min wash
in 5% Blotto in 1× TBS. After the washing, the nitrocellulose
membrane was incubated in goat anti-rabbit horseradish
peroxidase-linked secondary antibody diluted 1:1,000 in 5% Blotto in
1× TBS. Finally, substrates for enhanced chemiluminescent (Amersham
Life Science, Little Chalfont Bucks, UK) reaction were applied to all
nitrocellulose membranes, which were exposed to X-ray film (Eastman
Kodak) and developed by using standard techniques. Densitometry was
performed on the X-ray films, and immunoreactivity was expressed as a
percentage of the 21% nonstretch group.
TNF-
and Il-6 cytokine analysis.
After compliance measurements, the lungs for cytokine analysis were
lavaged with 2 × 1 ml of 0.15 M NaCl. Each lavage was instilled
and withdrawn three times and centrifuged at 200 g for 10 min at 4°C. The supernatant was divided into four equal aliquots, immediately snap frozen in liquid nitrogen, and stored at
70°C until further use. The concentration of TNF-
and Il-6 were measured in all samples by using separate opti-eia ELISA kits specific for each
cytokine, following the instructions provided by the manufacturer
(PharMingen, San Diego, CA).
Statistical analysis. All data are presented as means ± SE. Statistical analysis were performed by using a two-way ANOVA, with a Tukey's post hoc test, to explore any interactive effects. A one-way ANOVA, with a Tukey's post hoc test, was used to explore differences among specific groups. SPSS statistical software package for Windows, version 9.0.0 (SPSS Chicago, IL,), was used to perform the statistical comparisons. Differences between groups were considered statistically significant at probability values of <0.05.
| |
RESULTS |
|---|
|
|
|---|
All mice exposed to either 21 or >90% oxygen survived the entire 48-h exposure period. There were no significant differences observed between the initial and death masses of mice exposed to 21% oxygen (n = 50) compared with the mice exposed to >90% oxygen (n = 56), nor were there any differences observed between the initial and death masses within each of the 48-h exposure groups. The BAL volumes used to analyze the surfactant for the 21% nonstretch group was 2.4 ± 0.1 ml, which was not different from all other groups. Similarly, BAL volumes recovered from lungs used to analyze the inflammatory cytokines were not significantly different among all groups (21% nonstretch = 1.6 ± 0.1 ml).
The PIP measurements obtained from both stretch groups are presented in
Fig. 1A. At the time 0 point, the 21% + stretch group and the >90% + stretch group had
PIP values that were not statistically different. However, after 30 min
of ventilation, the >90% + stretch group had a significantly higher
PIP compared with the 21% + stretch group (Fig. 1A); this
difference remained significant until the end of the ventilation
period.
|
Analysis of static pressure-volume curves, shown in Fig. 1B, indicated no significant differences between the 21% nonstretch group and the >90% nonstretch group (Fig. 1B). The 21% + stretch group exhibited a significantly reduced compliance, as noted by the volume at a maximal pressure of 25 cmH20, compared with both nonstretch groups. Furthermore, the >90% + stretch group had a significantly reduced compliance compared with all other groups (Fig. 1B).
Table 1 shows the amount of total protein
in the BAL. There were no significant differences in the total protein
recovered from BAL (µg/g body wt) among the 21% nonstretch, >90%
nonstretch, and 21% + stretch groups. The amount of total protein was
significantly higher in the >90% + stretch group compared with all
other groups (Table 1).
|
Surfactant analysis.
No significant difference was observed when comparing the amount of TS
between the 21% nonstretch and >90% nonstretch groups (Fig.
2A). The 21% + stretch group
had a significant increase in TS compared with all other groups. The
>90% + stretch group had a significantly greater amount of TS
compared with both nonstretch groups, but this value was significantly
less than the 21% + stretch group (Fig. 2A). Statistical
comparison of the amounts of LA indicates that LA was significantly
higher in the 21% + stretch group compared with the three other groups
(Fig. 2A). There was no significant difference in the amount
of SAs recovered in the BAL among all groups (Fig. 2A).
Figure 2B shows the LA expressed as a percentage of the TS
to determine the contribution of LA. The results show that both >90%
groups had significantly lower percent LA compared with both 21%
groups (Fig. 2B).
|
|
|
|
|
Cytokine analysis in BAL.
The concentration of TNF-
was not significantly different among the
21% nonstretch, >90% nonstretch, and 21% + stretch groups (Fig.
6A). The >90% + stretch
group had a significantly higher concentration of TNF-
compared with
all other groups (Fig. 6A). The concentration of IL-6 was
not significantly different between the two nonstretch groups.
Similarly, the IL-6 concentration in the 21% + stretch and the >90% + stretch groups were not significantly different. Examination of the
effects of stretch revealed that the two stretch groups had
significantly higher concentration of IL-6 compared with both
nonstretch groups (Fig. 6B).
|
| |
DISCUSSION |
|---|
|
|
|---|
Mechanical ventilation is an essential but potentially harmful supportive therapy for patients with ALI and ARDS (3, 9). Numerous investigations into optimal ventilation strategies have been reported (6, 7, 27, 29). One specific component of mechanical ventilation, namely the stretch associated with lung inflation, has recently been proven to be a significant contributor to the damaging effects of this intervention (9, 28). In the study reported by the ARDS Network (6), it was demonstrated that ventilation with tidal volumes of 6 ml/kg (low stretch) compared with 12 ml/kg (high stretch) resulted in significantly lower mortality and increased ventilator-free days in patients with ALI/ARDS. In this clinical study as well as in other smaller trials, oxygen concentrations delivered to the patient were titrated to maintain blood-gas values (5, 6, 27). However, exposures to higher concentrations of oxygen have also been shown to cause damage to the lung (16). This information was our rationale to examine the effects of prolonged exposure to high oxygen concentrations on the lung in the context of lung stretch. On the basis of previous observations in mice, we hypothesized that alterations of the pulmonary surfactant system represented a mechanism by which deleterious effects of stretch were propagated (16, 31).
Our experimental approach was to first expose mice to room air or high oxygen and subsequently expose the isolated lung to either nonstretch or stretch. We utilized 48 h of exposure to >90% oxygen because this condition by itself does not result in lung dysfunction (2). The advantages of this approach in mice include the possibility to utilize transgenically modified animals in the future. The ex vivo approach allows for an extreme high-stretch protocol (tidal volume of 20 ml/kg) to potentially observe differences over the relatively short timeframe, which also minimized the 21% + stretch group exposure to the inspired oxygen fraction of 1.0. Obvious disadvantages include the lack of physiological measurements, the potentially contributing effects of ischemia of the lung, and the discrepancy between normal mouse breathing patterns and those used in the study (31). To overcome these limitations, additional studies approaching the hypothesis by utilizing an in vivo approach are therefore warranted.
The main conclusion from our experiments was that mild oxidative stress
and high-stretch mechanical ventilation deleteriously affects lung
function to a greater degree than stretch alone. Lung compliance was
unaffected by oxygen exposure alone compared with air exposure.
However, when oxygen-exposed lungs were subsequently ventilated,
compliance was significantly decreased compared with the ventilated
air-exposed lungs. A similar conclusion that oxygen exposure and
ventilation together contribute to progressive lung damage was reported
by Davis et al. (8). In our experiment, subsequent to
compliance measurements, we analyzed the pulmonary surfactant system
and concentrations of TNF-
and IL-6 in the lung on the basis of
previous studies that implicated these components in the development of
lung dysfunction (16, 31).
The biophysical function of pulmonary surfactant is to reduce the surface tension at the air-liquid interface of the alveoli (22). The active subfraction of surfactant, the LA, accomplishes this function by forming a DPPC-containing lipid film at the air-liquid interface. Impairment of this process results in decreased lung compliance. Compared with all other groups, the surfactant from lungs exposed to oxygen and stretch had a decreased amount of DPPC, decreased amounts of immunoreactive SP-D, and impaired adsorptive properties. This >90% + stretch group also had significantly greater amounts of non-SPs in the lavage that are known to inhibit surfactant function. The overall conclusion from those measurements is that, compared with all other groups, the >90% + stretch group had a significantly impaired surfactant system that was likely responsible for the decreased compliance.
A limitation of the present study is that prolonged oxygen exposure and stretch were administered separately rather than together, as would occur in mechanically ventilated patients (5, 6, 27). We would still suggest that our results reflect the clinical situation in which high oxygen is administered to a patient for a prolonged period of time and is combined with potential areas of overdistension of the lung due to the heterogeneous nature of the lung injury (13). Furthermore, our experimental design allowed us to observe individual effects of the two aspects of mechanical ventilation. In this regard, it was interesting that the oxygen exposure resulted in relative minor alterations of surfactant, such as a decreased percentage of LA and changes in protein and mRNA level of SP-A, but without significant lung injury. SP-A is important in the formation of tubular myelin and stabilization of LA structures by counteracting the protein inhibition of surfactant and in-host defense functions (20). These functions imply a beneficial role for SP-A in situations of lung stress. Thus, in our experiments, the reduced SP-A protein in the lung because of oxygen exposure may have been responsible for making the lung more susceptible to the effects of lung stretch. One specific example of this potential mechanism is through counteracting protein inhibition. Lung stretch was shown to induce an increase in protein in the lavage. It is possible that in the 21% + stretch group SP-A was able to counteract the inhibitory effects of these proteins, whereas in the >90% + stretch group lower amounts of SP-A allowed for an inhibition of surface tension reduction.
Whereas the above discussion focuses on SP-A, other SPs may also have been involved. Analysis of mRNA levels of the SPs revealed similar patterns for the four proteins with respect to the effects to oxygen exposure and stretch, and, although only SP-A and SP-D reached statistical significance, this was likely due to the low n values used in this analysis (n = 3/group). The overall decrease in mRNA levels of the SPs and the decreased amounts of SP-A and SP-D in lung homogenate may implicate general effects of oxygen exposure and stretch on type II cell metabolism. We did not determine whether the effects of hyperoxia and stretch on SPs in the lung homogenate were associated with decreased amounts of these proteins in the lavage. We did, however, observe a relative decrease in DPPC in the lavage from the >90% + stretch group, which could also be related to altered, type II cell metabolism. On the basis of the relative increase in lysophosphatidylcholine in this >90% + stretch group, increased phospholipase A2 activity may be an alternative explanation for this specific finding (15).
It has been suggested that mechanical ventilation could be a
contributor to multiorgan dysfunction (26). Although some
controversy exists, mechanical ventilation has been reported to
significantly affect inflammatory mediator release (25,
28). To test whether the combination of high oxygen and high
stretch impacts host defense, we measured two major cytokines in the
BAL, TNF-
and IL-6. Interestingly, the responses to the experimental
conditions differed between these two cytokines. IL-6 was detected in
the BAL after stretch regardless of oxygen exposure. The
stretch-induced increase in IL-6 concentration is consistent with
clinical studies in which patients were ventilated with low- and
high-stretch strategies. In these studies, increased IL-6
concentrations were observed in the BAL fluid (24) and in
plasma (6). Although it did not reach statistical
significance, stretch increased TNF-
concentrations to a similar
extent as previously reported (31). The concentrations of
TNF-
were not increased by hyperoxia, but the combination of
hyperoxia and stretch resulted in a significance increase in the lavage
values of this cytokine. Injection of TNF-
into the lung can cause
lung dysfunction and alterations of the pulmonary surfactant system
(21, 23). It is thus possible that the increased TNF-
concentrations in the >90% + stretch group may have contributed to
the decreased compliance, although this seems unlikely considering the
short period of stretch utilized.
Overall, we propose that the combinatorial effects of high oxygen concentration and high stretch mechanical ventilation can propagate ALI by altering pulmonary surfactant and possibly culminate to multiple organ failure syndrome via the release of proinflammatory mediators. Future in vivo and clinical studies are warranted to examine this concept further.
| |
ACKNOWLEDGEMENTS |
|---|
The authors thank Robert Harbottle and Dr. Li-Juan Yao for technical assistance and Drs James Lewis and Fred Possmayer for helpful discussions. We also acknowledge Dr. John Shannon for providing the original method for surfactant-associated protein RNAse protection assay, Dr. Henk Haagsman for supplying the anti-SP-A antibody, and Dr. Jo Rae Wright for providing us with anti-SP-D antibody.
| |
FOOTNOTES |
|---|
This study was funded by Canadian Institutes of Health Research. T. C. Bailey is supported by the Dr. David McCourtie Fellowship from the Ontario Thoracic Society.
Address for reprint requests and other correspondence: T. C. Bailey, Lawson Health Research Institute H417, 268 Grosvenor St., London, ON, Canada N6A 4V2 (E-mail: tbailey2{at}uwo.ca).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
First published November 15, 2002;10.1152/japplphysiol.00619.2002
Received 9 July 2002; accepted in final form 13 November 2002.
| |
REFERENCES |
|---|
|
|
|---|
1.
Artigas, A,
Bernard GR,
Carlet J,
Dreyfuss D,
Gattinoni L,
Hudson L,
Lamy M,
Marini JJ,
Matthay MA,
Pinsky MR,
Spragg R,
and
Suter PM.
The American-European consensus conference on ARDS, part 2: ventilatory, pharmacologic, supportive therapy, study design strategies, and issues related to recovery and remodeling. acute respiratory distress syndrome.
Am J Respir Crit Care Med
157:
1332-1347,
1998.
2.
Bailey, TC,
Cavanagh C,
Mehta S,
Lewis J,
and
Veldhuizen RAW
Sepsis and hyperoxia effects on the pulmonary surfactant system in wild-type and iNOS knockout mice.
Eur Respir J
20:
177-182,
2002.
3.
Bernard, GR,
Artigas A,
Brigham KL,
Carlet J,
Falke K,
Hudson L,
Lamy M,
Legall JR,
Morris A,
Spragg R,
and
and the Consensus Committee
The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination.
Am J Respir Crit Care Med
149:
818-824,
1994.
4.
Bligh, EG,
and
Dyer WJ.
A rapid method of total lipid extraction and purification.
Can J Biochem Physiol
37:
911-917,
1959.
5.
Brochard, L,
Roudot-Thoraval F,
Roupie E,
Delclaux C,
Chastre J,
Fernandez-Mondejar E,
Clementi E,
Mancebo J,
Factor P,
Matamis D,
Ranieri M,
Blanch L,
Rodi G,
Mentec H,
Dreyfuss D,
Ferrer M,
Brun-Buisson C,
Tobin M,
and
Lemaire F.
Tidal volume reduction for prevention of ventilator-induced lung injury in acute respiratory distress syndrome. The Multicenter Trail Group on tidal volume reduction in ARDS.
Am J Respir Crit Care Med
158:
1831-1838,
1998.
6.
Brower, RG,
Matthay MA,
Morris A,
Schoenfeld D,
Thompson BT,
and
Wheeler A.
Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The acute respiratory distress syndrome network.
N Engl J Med
342:
1301-1308,
2000.
7.
Brower, RG,
Shanholtz CB,
Fessler HE,
Shade DM,
White P,
Wiener CM,
Teeter JG,
Dodd-o JM,
Almog Y,
and
Piantadosi S.
Prospective, randomized, controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients.
Crit Care Med
27:
1492-1498,
1999.
8.
Davis, JM,
Penney DP,
Notter RH,
Metlay L,
Dickerson B,
and
Shapiro DL.
Lung injury in the neonatal piglet caused by hyperoxia and mechanical ventilation.
J Appl Physiol
67:
1007-1012,
1989.
9.
Dreyfuss, D,
and
Saumon G.
Ventilator-induced lung injury: lessons from experimental studies.
Am J Respir Crit Care Med
157:
294-323,
1998.
10.
Duck-Chong, CG.
A rapid sensitive method for determining phospholipid phosphorus involving digestion with magnesium nitrate.
Lipids
14:
492-497,
1979.
11.
Enhorning, G.
Pulsating bubble technique for evaluating pulmonary surfactant.
J Appl Physiol
43:
198-203,
1977.
12.
Frerking, I,
Gunther A,
Seeger W,
and
Pison U.
Pulmonary surfactant: functions, abnormalities and therapeutic options.
Intensive Care Med
27:
1699-1717,
2001.
13.
Gattinoni, L,
Pelosi P,
Crotti S,
and
Valenza F.
Effects of positive end-expiratory pressure on regional distribution of tidal volume and recruitment in adult respiratory distress syndrome.
Am J Respir Crit Care Med
151:
1807-1814,
1995.
14.
Godinez, MH,
and
Godinez RI.
Inspired oxygen concentration alters the phospholipids and protein content in the bronchoalveolar lavage-accessible space.
Crit Care Med
24:
862-869,
1996.
15.
Hite, RD,
Seeds MC,
Jacinto RB,
Balasubramanian R,
Waite M,
and
Bass D.
Hydrolysis of surfactant-associated phosphatidylcholine by mammalian secretory phospholipases a2.
Am J Physiol Lung Cell Mol Physiol
275:
L740-L747,
1998.
16.
Holm, BA,
Notter RH,
Siegle J,
and
Matalon S.
Pulmonary physiological and surfactant changes during injury and recovery from hyperoxia.
J Appl Physiol
59:
1402-1409,
1985.
17.
Lewis, JF,
Veldhuizen R,
Possmayer F,
Sibbald W,
Whitsett J,
Qanbar R,
and
McCaig L.
Altered alveolar surfactant is an early marker of acute lung injury in septic adult sheep.
Am J Respir Crit Care Med
150:
123-130,
1994.
18.
Lowry, OH,
Rosebrough NJ,
Farr AL,
and
Randall RJ.
Protein measurement with the Folin reagent.
J Biol Chem
193:
265-275,
1951.
19.
Martin, TR.
Cytokines and the acute respiratory distress syndrome (ARDS): a question of balance.
Nat Med
3:
272-273,
1997.
20.
McCormack, FX.
Structure, processing and properties of surfactant protein A.
Biochim Biophys Acta
1408:
109-131,
1998.
21.
Porter, SB.
Current status of clinical trials with anti-TNF.
Chest
112:
339-341,
1997.
22.
Possmayer, F,
Yu SH,
Weber JM,
and
Harding PG.
Pulmonary surfactant.
Can J Biochem Cell Biol
62:
1121-1133,
1984.
23.
Pryhuber, GS,
Bachurski C,
Hirsh R,
Bacon A,
and
Whitsett JA.
Tumor necrosis factor-
decreases surfactant protein B mRNA in murine lung.
Am J Physiol Lung Cell Mol Physiol
270:
L714-L721,
1996.
24.
Ranieri, VM,
Suter PM,
Tortorella C,
De Tullio R,
Dayer JM,
Brienza A,
Bruno F,
and
Slutsky AS.
Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial.
JAMA
282:
54-61,
1999.
25.
Ricard, JD,
Dreyfuss D,
and
Saumon G.
Production of inflammatory cytokines in ventilator-induced lung injury: a reappraisal.
Am J Respir Crit Care Med
163:
1176-1180,
2001.
26.
Slutsky, AS,
and
Tremblay LN.
Multi system organ failure: is mechanical ventilation a contributing factor?
Am J Respir Crit Care Med
157:
1721-1725,
1998.
27.
Stewart, TE,
Meade MO,
Cook DJ,
Granton JT,
Hodder RV,
Lapinsky SE,
Mazer CD,
McLean RF,
Rogovein TS,
Schouten BD,
Todd TR,
and
Slutsky AS.
Evaluation of a ventilation strategy to prevent barotrauma in patients at high risk for acute respiratory distress syndrome. Pressure- and volume-limited ventilation strategy group.
N Engl J Med
338:
355-361,
1998.
28.
Tremblay, L,
Valenza F,
Ribeiro SP,
Li J,
and
Slutsky AS.
Injurious ventilatory strategies increase cytokines and c-fos mRNA expression in an isolated rat lung model.
J Clin Invest
99:
944-952,
1997.
29.
Tremblay, LN,
and
Slutsky AS.
Ventilator-induced injury: from barotrauma to biotrauma.
Proc Assoc Am Physicians
110:
482-488,
1998.
30.
Veldhuizen, RAW,
Marcou J,
Yao LJ,
McCaig L,
Ito Y,
and
Lewis JF.
Alveolar surfactant aggregate conversion in ventilated normal and injured rabbits.
Am J Physiol Lung Cell Mol Physiol
270:
L152-L158,
1996.
31.
Veldhuizen, RAW,
Slutsky AS,
Joseph M,
and
McCaig L.
Effects of mechanical ventilation of isolated mouse lungs on pulmonary surfactant and inflammatory cytokines.
Eur Respir J
17:
488-494,
2001.
32.
Yamada, T,
Ikegami M,
and
Jobe AH.
Effects of surfactant subfractions on preterm rabbit lung function.
Pediatr Res
27:
592-598,
1990.
This article has been cited by other articles:
![]() |
E. L. Martin, T. A. Sheikh, K. J. Leco, J. F. Lewis, and R. A. W. Veldhuizen Contribution of alveolar macrophages to the response of the TIMP-3 null lung during a septic insult Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L779 - L789. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. P. Desai, S. E. Sinclair, K. E. Chapman, A. Hassid, and C. M. Waters High tidal volume mechanical ventilation with hyperoxia alters alveolar type II cell adhesion Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L769 - L778. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Keating, L. Rahman, J. Francis, A. Petersen, F. Possmayer, R. Veldhuizen, and N. O. Petersen Effect of Cholesterol on the Biophysical and Physiological Properties of a Clinical Pulmonary Surfactant Biophys. J., August 15, 2007; 93(4): 1391 - 1401. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Martin, L. A. McCaig, B. Z. Moyer, M. C. Pape, K. J. Leco, J. F. Lewis, and R. A. W. Veldhuizen Differential response of TIMP-3 null mice to the lung insults of sepsis, mechanical ventilation, and hyperoxia Am J Physiol Lung Cell Mol Physiol, August 1, 2005; 289(2): L244 - L251. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. Bailey, K. A. Da Silva, J. F. Lewis, K. Rodriguez-Capote, F. Possmayer, and R. A. W. Veldhuizen Physiological and inflammatory response to instillation of an oxidized surfactant in a rat model of surfactant deficiency J Appl Physiol, May 1, 2004; 96(5): 1674 - 1680. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Martin, B. Z. Moyer, M. C. Pape, B. Starcher, K. J. Leco, and R. A. W. Veldhuizen Negative impact of tissue inhibitor of metalloproteinase-3 null mutation on lung structure and function in response to sepsis Am J Physiol Lung Cell Mol Physiol, December 1, 2003; 285(6): L1222 - L1232. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |